Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
Background: Patients with atrial fibrillation undergoing percutaneous coronary intervention have indications for oral anticoagulation and dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor. The concurrent use of all three agents, termed triple oral antithrombotic therapy (T...
Guardado en:
Autores principales: | Abdelmoniem Moustafa, Mohammad Khan, Marei Saud, Alsamman Mohd Abdalla, Baig Amer, Saad Muhammad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73c433c898ad4a0c9e94f88cf8ea8637 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Abdelmoniem Moustafa, et al.
Publicado: (2019) -
Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Yutao Guo, et al.
Publicado: (2010) -
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
por: Guo Y, et al.
Publicado: (2011) -
Antithrombotic therapy and its impact on prognosis in patients with atrial fibrillation and myocardial infarction. Long-term observation results
por: Mariia V. Soloveva, et al.
Publicado: (2021) -
Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
por: Arahata M, et al.
Publicado: (2018)